NLRP3 and osteoporosis: AR/PCC alleviated diabetes-related osteoporosis by upregulating the antioxidant response protein (Nrf2) to reduce the activation of the NLRP3-mediated canonical pyroptosis pathway in vertebral osteoblasts.